Hesperos, Inc.

[On Demand]
Hesperos, Inc. is accelerating drug discovery by providing safety and efficacy testing of chemicals and novel therapeutics for the pharmaceutical, cosmetic, and food industries using its patented, Human-on-a-Chip multi-organ, microphysiological system. This breakthrough technology enables unprecedented preclinical insight into disease states and whether a novel compound will be safe and effective for treatment in humans - something that previously required costly animal testing and human trials to determine.

The Human-on-a-Chip is a reconfigurable, multi-organ in vitro platform that reproduces the functional aspects of human physiology enabling evaluation of the efficacy and off-target toxicity of parent compounds and their metabolites for both single drug treatments and drug-drug combinations.

Operating as a CRO, Hesperos offers compound safety and efficacy testing services using the Human-on-a-Chip platform.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Florida
Company HQ Country:
United States
Year Founded:
2015
Main Therapeutic Focus:
Lead Product in Development:
Human-on-a-Chip
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
Chief Scientist
Hesperos, Inc.